Dina Chaya
Board member
Management
Wilson Therapeutics
Sweden
Biography
Born 1971. Board Member since 2015. Education: CFA charterholder, CFA Institute and BSc in natural sciences tripos, Cambridge University and MSc in development biology and PhD in molecular and cellular biology of development, Paris VI University. Other current assignments: Partner of NeoMed Management (Jersey) Limited. Board member of Oxular Ltd, TopiVert Ltd and TopiVert Pharma Ltd. Previous assignments (last five years): None. Position: Independent of the Company, executive management and major shareholders.
Research Interest
